Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | XL228 |
Trade Name | |
Synonyms | |
Drug Descriptions |
XL228 inhibits multiple tyrosine kinases, including the insulin-like growth factor 1 receptor (IGF1R), Src tyrosine kinase, and Bcr-Abl tyrosine kinase, which can lead to cell growth inhibition (Mol Cancer Ther 2009;8(12 Suppl):C192, PMID: 20557276). |
DrugClasses | BCR-ABL Inhibitor 31 IGF-1R Inhibitor 17 SRC Inhibitor 31 |
CAS Registry Number | 898280-07-4 |
NCIT ID | C68929 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
XL228 | XL228 | 0 | 0 |